Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Jul 23
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for…
17 Jul 23
Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™…
17 Jul 23
Medicxi asset-centric portfolio company Versanis Bio to be acquired by Lilly to improve patient outcomes in cardiometabolic diseases.
17 Jul 23
Combined company is expected to have cash balance of approximately $170m at close, which is expected to provide…
17 Jul 23
The Company intends to use the funds awarded by the National Institutes of Health for completion of its…
17 Jul 23
Colchicine's Approval Heightens the Need for Technologies Detecting Inflammation Specifically Related to Coronary Arteries
14 Jul 23
The two public-private partnerships are intended to accelerate the development of dispersible paediatric human immunodeficiency virus medicines
14 Jul 23
According to the data set of all 16 patients treated in this phase, CB-010 was generally well tolerated…
14 Jul 23
The MAA is based on results from the Phase 3 SPOTLIGHT and GLOW clinical trials
14 Jul 23
The acquisition of Continuum further reinforces Aspirion's market leadership in complex claims management specific to MVA and TPL…